Wei-Lin Wang is an experienced professional in the field of biotechnology and genetics, currently serving as the Manager of Cell-based Assay at CureVac since October 2017, focusing on potency assay development. Prior to this role, Wei-Lin Wang worked as a Consultant at ProQinase GmbH, conducting market studies and supporting business development in China. Wei-Lin Wang has a strong background in scientific research, having held positions as a Praktikantin/Scientist at Artes Biotechnology GmbH and a Postdoctoral Fellow at Albert Einstein College of Medicine, where substantial work on histone modifications and transcriptional regulation was conducted. Wei-Lin Wang began academic pursuits with a Master's Degree in Genetics from National Yang Ming University, followed by a Ph.D. in Genetics from Albert Einstein College of Medicine.
This person is not in any teams
This person is not in any offices